Comment on CMS-2026-1255-0001

Summary: The Cigna Group supports the proposed rule's goals of modernizing prior authorization (PA) and improving interoperability, but they advocate for specific modifications to ensure operational feasibility. They recommend a longer implementation timeline (at least 24 months), flexibility for integrated regimen-based PA workflows for complex therapies, and the streamlining of reporting requirements to avoid duplication.